New analysis examines the darknet's opioid purchases

NewsGuard 100/100 Score

U.S. overdose deaths attributed to synthetic opioids, such as fentanyl, have increased from under 3,000 in 2013 to nearly 20,000 in 2016, making up half of all opioid-related overdose deaths.

These drugs are often purchased on the web's hidden "darknet." An analysis published in Contemporary Economic Policy that examined the darknet's opioid purchases from 2014 to 2016 found that vendors priced fentanyl in 2014 at a 90% discount compared with an equivalent dose of heroin.

Furthermore, fentanyl's retail price declined by 50% to $0.21 between 2014 and 2016, exacerbating this difference. "By 2016 a lethal dose of fentanyl on the dark web had fallen to under $2.50, and with bulk pricing a lethal dose cost approximately $1.00," said author Jacob N. Miller, of Southern Utah University.

The research also suggested that although U.S. legal actions had minimal lasting effects of darknet market disruption, regulatory actions in China intended to curb the manufacturing of fentanyl coincided with a halt in the downward trend in fentanyl prices.

Source:
Journal reference:

Miller, J. N. (2019) The War on Drugs 2.0: Darknet Fentanyl's Rise and the Effects of Regulatory and Law Enforcement Action. Contemporary Economic Policy. doi.org/10.1111/coep.12447.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Are we eating what's really good for us? New insights into macronutrients and chronic disease